Comparing the Efficacy of Myosin Inhibition Versus Thin Filament Calcium Desensitization for Treatment of Pediatric Restrictive Cardiomyopathy Using a Patient-Derived hiPSC Model
Paediatrics
Comparing the Efficacy of Myosin Inhibition Versus Thin Filament Calcium Desensitization for Treatment of Pediatric Restrictive Cardiomyopathy Using a Patient-Derived hiPSC Model
Paediatrics

Comparing the Efficacy of Myosin Inhibition Versus Thin Filament Calcium Desensitization for Treatment of Pediatric Restrictive Cardiomyopathy Using a Patient-Derived hiPSC Model

Circ Genom Precis Med. 2025 Nov 12:e005464. doi: 10.1161/CIRCGEN.125.005464. Online ahead of print.

NO ABSTRACT

PMID:41221584 | DOI:10.1161/CIRCGEN.125.005464